Matthew Greenfield

Matthew Greenfield is the associate director, laboratory operations at Verve Therapeutics. Matt has over 20 years of experience in the pharmaceutical industry. Prior to working at Verve, Matt worked as a researcher for both EPIX and Ariad Pharmaceuticals contributing to the development of three approved medicines (Vasovist, Iclusig and Allunbrig). He most recently served as the associate director of lab operations at Alkermes. In addition to his position at Verve, Matt serves on the board of health in Middleton, Massachusetts. Matt received his B.S. in chemistry from the University of New Hampshire.